Latest 10-K annual reports

MKS Inc. reports robust 2025 revenue and net income growth driven by semiconductor and electronics markets, alongside significant debt refinancing and an increased quarterly dividend.

Washington Trust Bancorp, Inc. reported a significant rebound in net income for 2025, reaching $52.2 million, driven by balance sheet repositioning and growth in wealth management and mortgage banking revenues.

Zions Bancorporation, N.A. reported solid financial performance in 2025 with increased net earnings, diluted EPS, and improved efficiency, while maintaining strong capital ratios.

Gentex Corporation reports 10% net sales growth in 2025, driven by strategic acquisitions, despite a decline in core sales and a drop in net income.

Chevron Corporation reports a decrease in net income for 2025 despite significant production growth driven by the Hess acquisition and strategic project ramp-ups, while facing increased debt and ongoing legal challenges.

J.B. Hunt Transport Services, Inc. reports mixed financial results for 2025, with a slight revenue decrease but improved operating income and strategic investments in technology and efficiency.

Southern First Bancshares, Inc. reported a significant increase in net income and improved efficiency for the fiscal year ended December 31, 2025, driven by higher net interest income and strategic growth.

Regions Financial Corporation announced a significant increase in net income and diluted earnings per share for 2025, alongside a new $3.0 billion share repurchase authorization.

Williams Companies Inc. announced an 18% increase in net income for 2025, driven by strategic acquisitions and significant expansion projects across its natural gas infrastructure.

Ryman Hospitality Properties, Inc. reported increased total revenues in 2025 driven by strategic acquisitions and entertainment growth, though net income declined.

Labcorp Holdings Inc. reported a 7.2% revenue increase to $13.95 billion in 2025, driven by organic growth and strategic acquisitions, while navigating healthcare cost pressures and investing in specialty testing and AI.

Clearway Energy, Inc. reports a net income of $169 million for 2025, driven by significant acquisitions in solar and BESS, despite a material weakness in internal control over financial reporting.

Invesco Ltd. reported a net loss of $726.3 million for 2025, primarily due to a significant non-cash impairment of intangible assets, despite growth in Assets Under Management and strategic divestitures.

BAB, Inc. announced a rise in net income and earnings per share for fiscal year 2025, despite a slight decrease in total revenues and unit count.

Constellation Energy reports a decrease in GAAP Net Income for 2025 despite strategic Calpine acquisition and strong operational performance in its clean energy fleet.

The Chefs' Warehouse reported robust 9.4% net sales growth in fiscal 2025, driven by organic expansion and strategic acquisitions, while also amending its credit agreement to reduce interest rates on term loans.

McDonald's Corporation reports robust 2025 financial performance with global comparable sales up 3.1% and Systemwide sales increasing 7%, driven by its Accelerating the Arches strategy and significant restaurant expansion.

Iovance Biotherapeutics reports increased Amtagvi revenue and ongoing clinical trials, alongside a net loss of $391.0 million for fiscal year 2025.

Allison Transmission Holdings, Inc. reports a 7% decrease in 2025 net sales to $3.01 billion, driven by North America On-Highway and Global Off-Highway declines, while completing a significant acquisition to diversify its off-highway business.

Elanco Animal Health reported a net loss of $232 million in 2025, driven by significant restructuring charges and asset impairments, despite revenue growth and new product launches.

Cipher Digital Inc. (formerly Cipher Mining Inc.) is strategically shifting from bitcoin mining to high-performance computing (HPC) data center development, securing major leases with Amazon and Fluidstack/Google, despite reporting a significant net loss of $822.2 million in 2025.

Mohawk Industries reports a decrease in 2025 net earnings and operating income amidst challenging market conditions, while pursuing strategic restructuring and product innovation.

Harmony Biosciences reports strong 2025 revenue growth for WAKIX, expands its neuroscience pipeline, and navigates generic competition.

Portillo's Inc. reported a 3.0% revenue increase to $732.1 million in fiscal 2025, but net income and EBITDA declined, prompting a strategic reset in its new restaurant expansion approach.

Artelo Biosciences reported promising interim clinical trial results for its drug candidates but faces substantial doubt about its ability to continue as a going concern and a Nasdaq delisting threat due to insufficient stockholders' equity.

Shoals Technologies Group, a leader in solar and BESS electrical infrastructure, reported a 19% revenue increase in 2025, driven by higher demand for utility-scale solar projects.

The Chemours Company reported a significant net loss in 2025, driven by substantial litigation charges and operational challenges in its Titanium Technologies and Advanced Performance Materials segments, despite growth in Thermal & Specialized Solutions.

First Watch Restaurant Group, Inc. reported a 20.3% increase in total revenues to $1.2 billion in 2025, driven by new restaurant openings and positive same-restaurant sales growth, despite commodity and labor inflation.

Beam Therapeutics reported positive Phase 1/2 clinical data for its sickle cell disease candidate, risto-cel, and secured a $500 million credit facility, while continuing to advance its broad gene editing pipeline.

Fulcrum Therapeutics' 2025 annual report highlights promising Phase 1b pociredir data for sickle cell disease and a strengthened financial position, despite a significant net loss.